Allergy is a common immune disorder characterized by raised IgE levels, which leads to clinical disorders such as asthma, rhinitis and eczema. Our understanding of the pathogenesis of allergic disease is largely dependent on our current understanding of the related pathophysiology and the available technology. Recent advances in molecular biology techniques have allowed a rapid and accurate identification of polymorphisms in various genes that may be important for determining the susceptibility to allergic disorders. In this review, we present some developments in genetic studies of allergic disease with particular focus on asthma and atopy in the Japanese population.
INTRODUCTION
Atopic and allergic diseases such as asthma, rhinitis, and eczema were rare a few decades ago but, today, constitute an increasingly severe public health problem especially in developed countries. 1, 2 The rising prevalence of allergic disease over the past decades suggests that environmental and lifestyle factors are important. However, atopy clustering in families suggest a strong genetic component to allergic disease. 3, 4 Significant progress has been made in the study of atopy genetics during the last decade since the Oxford group, in 1989, first reported a linkage between generalized IgE responsiveness and a DNA polymorphism on chromosome 11q13 in British families. 5 Atopy is a key predisposing factor in the development of bronchial asthma between the ages of 3 and 20 years. 6, 7 The majority of asthmatics are also atopic, with manifestation of allergic diathesis including clinical allergy to aeroallergens and foods, or subclinical allergy manifested by skin test reactivity to allergen or elevated serum IgE . Bronchial hyperresponsiveness (BHR), an exaggerated bronchospastic response to specific and non-specific substances, represents the physiological hallmark of asthma induced by Th2 cytokines such as interleukin (IL)-4, -5, -9, -10 and -13. Twin studies have revealed that heritability estimates of asthma vary between 36% and 79% . [8] [9] [10] Importantly, there is evidence that genetic liability for asthma , BHR and allergic traits are regulated through distinct loci, although there is likely some shared overlap as well . 11 To date , several multiple genome-wide linkage studies for asthma and allergy have been performed, and have identified no fewer than 20 distinct chromosomal regions with linkage to asthma or related traits in different populations. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] The known chromosomes 5q, 11q, 12q, and 16p are major candidates that may contribute to the development of asthma and allergy . Recently , Yokouchi et al. 21 conducted a genome screen in Japanese children with hay fever (orchard grass pollinosis) , and found linkage of chromosomes 3p, 5q, 12p and 12q with this seasonal allergic rhinitis. Interestingly, all of these regions have been previously reported to harbor candidate genes for asthma and atopy Allergology International. 2005; 54:359-365 
FCERIB GENE
The first genetic region reported to show linkage to atopy was chromosome 11q. 5 A significant portion of atopic asthmatic families in Caucasian and Japanese populations may be linked to chromosome 11 q 13 through the maternal line . 22, 23 The β-subunit of the high-affinity IgE receptor (FCERIB) gene has been mapped to chromosome 11 q 13 and is a candidate gene for atopy [24] [25] [26] [27] because of its important role in initiating type I hypersensitivity reactions by mast cells and basophils.
The FCERIB gene is composed of seven exons and six introns, spanning approximately 11 kb. 28 At least eight variants of this gene have been identified that include three coding variants (Ile181Leu, Val183Leu and Glu237Gly). [29] [30] [31] The minor allele of Glu237Gly has been found at a low frequency ( approximately 5%) in a number of populations. However, the Gly237 allele occurs at a relatively high frequency in the Japanese population ( approximately 20% ) and has been found to be associated with atopic asthma (particularly in childhood asthma), allergic rhinitis (due to house dust mite and! or Japanese cedar pollen) , as well as with high serum total and specific IgE levels. 31, 32 
IL4 AND IL13 GENES
IL-4 and IL-13 are type 2 cytokines and play a central role in IgE-dependent inflammatory reactions. 6, 7 IL-4 plays a central role in B cells switching to IgE antibody production, and in the maturation of helper Tcells towards the Th2 phenotype. IL-4 and IL-13 operate through the IL-4 receptor (IL-4R) or IL-13R, respectively . Both receptors share the IL-4 Rα chain , and promote STAT6 (signal transducer and activator of transcription 6) activation. Mice deficient in IL4, IL 13, IL4r or Stat6 lack IgE synthesis and Th2-type reactions, 7 therefore, genetic variants of IL-4! IL-13 signalling might be crucial for the development of atopic disorders IL4 and IL13 genes are localized within 25 kb on the proximal portion of chromosome 5q31, to which genome searches have identified a strong linkage with asthma and atopy. 13, 14 A dinucleotide repeat in the third intron of IL4 is linked to total serum IgE levels but not to asthma in Caucasian populations , 33 whereas linkage to both high IgE levels and asthma has been found in a Japanese population . 34 These findings support the candidacy of IL4 as an atopy locus on 5q31. To date, five putative variants have been reported in the IL4 promoter region -four of them are very rare. 35, 36 A variant in the IL4 promoter, −590 C ! T , has been related to higher IgE levels in the Japanese population. 34 Deichmann et al. 37 performed a systematic search for variations in the IL4RA gene and found 13 polymorphic variants in the coding region , including seven variants that resulted in amino acid substitution. The prevalence of Ile50 has been demonstrated to be higher than Val 50 in individuals with atopic asthma, especially during childhood in the Japanese population . 38 Recently , Nakamura et al. 39 reported significant changes in the prevalence of Ile50Val and Glu375Ala variants of IL4RA in healthy subjects with a normal IgE value compared with those in healthy subjects with a higher allergen-specific IgE value in the Japanese population . Furthermore , it was suggested that Ile50Val and Glu375 Ala seem to be related to Japanese cedar pollen sensitization, and subjects with Ile50 or Glu375 might develop Japanese cedar pollinosis (JCPsis) with increased exposure to cedar pollen IL-13 operates through IL-13 R , a heterodimer of IL-4Rα and IL-13Rα1 chains. 6,7,40 IL-13 is crucial for allergen-induced BHR in experimental animals and may be relevant to human asthma. 41, 42 Significantly higher IL-13 levels have been found in asthmatic patients with and without atopy. 43 A novel variant of human IL13, Arg110 Gln , on chromosome 5 q 31 was found to be associated with asthma rather than IgE levels in case-control populations from Britain and Japan ; the variant also predicted asthma and higher serum IL-13 levels in a general Japanese paediatric population . 44, 45 Moreover , Immunohistochemistry demonstrated that both subunits of IL-13R are prominently expressed in bronchial epithelium and smooth muscle from asthmatic subjects, and detailed molecular modelling analyses indicated that residue 110 of IL13, the site of the charge-modifying variants Arg and Gln, is an important constituent in the internal constitution of the ligand and crucial in ligandreceptor interaction. 44 These results suggest that the IL13 variant Arg110Gln might be involved in asthma pathogenesis. However, recent association studies by Miyazawa et al. 46 and our group 47 showed that this potentially functional variant did not contribute significantly to JCPsis susceptibility and cedar pollenspecific IgE concentration in the Japanese populations. Further studies will be necessary to assess the relationship between other variants in IL13 and susceptibility to JCPsis.
IL12 AND IL18 GENES
IL-12 is expressed by activated macrophages that serve as an essential inducer of Th 1 cells development. IL-12 has been found to be important for sustaining a sufficient number of memory! effector Th1 cells which mediate long-term protection to an intracellular pathogen, while IL-18 can induce the interferon (IFN)-γ production of T cells. The combination of IL-12 and IL-18 has been shown to inhibit IL-4 dependent IgE and IgG 1 production , and enhance IgG2a production of B cells. In addition, administration of IL-18 together with IL-12 is important in sustaining Th1 responses and monokine production Several polymorphisms of the IL12B gene (encoding IL-12 p40) have recently been reported to be associated with asthma-severity phenotype in ethnically diverse children . 48, 49 Although in a genome-wide screen, strong evidence for linkage of atopic asthma in childhood with marker D5S1352 (located close to IL12B) was found, 50 however a lack of association between the IL12B polymorphisms and susceptibility to atopic asthma or allergic rhinitis in the Japanese families was also reported , 51 suggesting that polymorphisms in IL12B are not likely to be associated with the development of atopy-related phenotypes in this study population. The influences of racial and ethnicspecific differences in environmental and! or genetic risk factors on the development of complex common disease may account for the conflicting findings
The contribution of IL-18 to asthma has been studied in human beings and mice. In humans, the level of serum IL-18 was elevated during acute asthmatic exacerbations 52 and secretion of IL-18 by peripheral blood mononuclear cells was increased in asthma and atopic dermatitis . 53 Yoshizawa et al. 54 reported that significantly higher serum IL-18 levels were found in patients with atopic dermatitis than in control subjects , and that serum IL-18 levels were correlated with disease severity and with the number of eosinophils in peripheral blood. However, reduced expression of IL-18 mRNA in atopic dermatitis has also been described. 55 An important role of IL-18 has also been found in rheumatoid arthritis, which is a typical Th1-mediated disease. 56 The human IL18 gene is located on chromosome 11q22.2 22.3, and it is composed of six exons and five introns spanning about 19.5 kb. Higa et al. 57 examined whether or not polymorphisms occurred in the coding region of the IL-18 gene and, if so, whether there was a relation between polymorphism and asthma. They detected one new polymorphism in the coding region of the IL-18 gene linked with substitution A to C at position 105, but this polymorphism was silent. The increase of the frequency of the A allele was found to be associated with increased susceptibility to asthma. There was also an increase of serum IL-18 levels in patients with allergic asthma compared with control subjects, but no significant association was detected between the IL-18 levels and genotypes of 105A! C polymorphism in IL18.
TLR2 AND TLR4 GENES
Gene-environment interaction is likely to impact on the development of allergic disease. 3, 4 The mammalian host defense against environmental pathogens can be classified into two major forms of immune response:innate and acquired . Innate immune responses are triggered through the binding of bacterial lipopolysaccharide (LPS) and other bacterial components to receptors such as CD14 and Toll-like receptors ( TLRs . Recent studies have revealed that TLRs play an important role in innate immune responses and subsequent activation of acquired immune responses. 58 To date, 10 distinct human TLRs have been identified and shown to mediate specific cellular responses to pathogen-associated molecular patterns. Binding of LPS to CD14 initiates cytoplasmatic signal transduction through the TLR4. 59 Common, cosegregating missense mutations (Asp 299Gly and Thr399Ile) in the TLR4 gene have been identified in humans and found to be associated with hyporesponsiveness to inhaled LPS. 60 A recent study in Swedish children showed that decreased LPSinduced IL-12 (p70) and IL-10 responses were associated with the Asp299Gly polymorphism of TLR4 and independently with asthma , especially atopic asthma. 61 In addition, this polymorphism was associated with a 4-fold higher prevalence of asthma in school-aged children. Also, genetic variation in the TLR2 gene was suggested to be a major determinant of the susceptibility to asthma and allergies in children of European farmers. 62 However , no evidence was found to support the argument that genetic variations in TLR2 and TLR4 contribute to the development of atopy-related phenotypes in a Japanese population. 63 The genes encoding TLRs show a high variability in human populations, but whether these genetic variations modify the interaction with microbial molecules and thereby modify the frequency of asthma and allergies is not yet known. This data is expected to be elucidated in future research.
ADAM33 GENE
Recent information regarding asthma genetics comes from the work of Van Eerdewegh and coworkers. 64 These investigators performed a genetic study by combining linkage and association approaches in Caucasian affected sib-pair families from the UK and the US, and identified ADAM33 (a disintegrin and metalloprotease domain 33) as a major susceptibility gene for asthma linked to BHR. The association of ADAM33 polymorphisms with asthma and related phenotypes has been subsequently replicated in several different populations. [65] [66] [67] [68] [69] Most recently, our group examined the association between ADAM33 polymorphisms and susceptibility to JCPsis, a most common seasonal allergic rhinitis in Japan . 70 We conducted a case-control association study among a Japanese population , involving 95 adult individuals with JCPsis and 95 healthy controls. A total of 22 single-nucleotide polymorphisms (SNPs) in the ADAM 33 gene were genotyped using PCRbased molecular methods . Six SNPs of ADAM33 gene, three in introns (7575G! A, 9073G! A and 12540 C ! T) and three in the coding region ( 10918 G ! C , 12433T! C and 12462C! T), were strongly associated with JCPsis susceptibility and most of the SNPs were in linkage disequilibrium with each other. A higher
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CONCLUDING REMARKS
The understanding of the genetics of asthma and allergy has evolved rapidly since the sequencing of the human genome and in this past year has led to the isolation of several novel asthma-susceptibility genes, such as ADAM33. Although these discoveries have shed new light on the pathophysiology of allergic disease, it is clear that no single genetic risk factor is responsible for the development of asthma and atopy. Cumulative information suggests that the development of the disease in an individual will depend upon the interaction of a number of genes together with various environmental factors . Recently , numerous studies have been carried out to examine the association between asthma or its related traits and genetic variations in candidate genes in ethnically diverse groups including the Japanese population (Table 1) . 72 The results from these studies have often shown discrepant outcomes in different populations. However, many of these studies are limited with respect to sample size, thereby severely hampering their interpretation due to the reduced statistical power. Also, allergy is a multifactorial disease affected by interacting genetic and environmental factors. However, it remains unknown how environmental and relevant variants interact. Future studies will continue to improve our understanding of the role of genetic variants, genegene interaction, and gene-environment interaction in the development of allergic diseases, and eventually reveal new approaches for modulating this system in ways that favorably affect disease mechanisms and clinical settings
